Ziyang Liu, Ali Ajam, Jun Huang, Yu-Sheng Yeh, Babak Razani
{"title":"心血管疾病发病机制中的谷氨酰胺-谷氨酸失衡。","authors":"Ziyang Liu, Ali Ajam, Jun Huang, Yu-Sheng Yeh, Babak Razani","doi":"10.1038/s44161-024-00575-0","DOIUrl":null,"url":null,"abstract":"Glutaminase-2 (GLS2) is crucial for glutamine metabolism and its deficiency causes increased plasma glutamine levels, disrupted extracellular matrix remodeling and accelerated plaque progression. Findings reveal a metabolic link between hepatic glutamine homeostasis and the vasculature and potential therapeutic strategies for cardiovascular disease.","PeriodicalId":74245,"journal":{"name":"Nature cardiovascular research","volume":"3 12","pages":"1377-1379"},"PeriodicalIF":9.4000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Glutamine–glutamate imbalance in the pathogenesis of cardiovascular disease\",\"authors\":\"Ziyang Liu, Ali Ajam, Jun Huang, Yu-Sheng Yeh, Babak Razani\",\"doi\":\"10.1038/s44161-024-00575-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Glutaminase-2 (GLS2) is crucial for glutamine metabolism and its deficiency causes increased plasma glutamine levels, disrupted extracellular matrix remodeling and accelerated plaque progression. Findings reveal a metabolic link between hepatic glutamine homeostasis and the vasculature and potential therapeutic strategies for cardiovascular disease.\",\"PeriodicalId\":74245,\"journal\":{\"name\":\"Nature cardiovascular research\",\"volume\":\"3 12\",\"pages\":\"1377-1379\"},\"PeriodicalIF\":9.4000,\"publicationDate\":\"2024-11-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature cardiovascular research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.nature.com/articles/s44161-024-00575-0\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature cardiovascular research","FirstCategoryId":"1085","ListUrlMain":"https://www.nature.com/articles/s44161-024-00575-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Glutamine–glutamate imbalance in the pathogenesis of cardiovascular disease
Glutaminase-2 (GLS2) is crucial for glutamine metabolism and its deficiency causes increased plasma glutamine levels, disrupted extracellular matrix remodeling and accelerated plaque progression. Findings reveal a metabolic link between hepatic glutamine homeostasis and the vasculature and potential therapeutic strategies for cardiovascular disease.